Four Republican Senators Say They Oppose Obamacare Replacement Plan

 
• By Sue Darcey
  
Generate a summary of this article
Listen to this article
Beta

In a March 6 letter to Sen. Majority Leader Mitch McConnell, R-Kent., four GOP senators said they oppose a Feb. 10 Obamacare "Repeal and Replace" plan that has been circulating around Congress because it does not provide stability or certainty for individuals in Medicaid expansion programs. A device tax repeal is included in the plan.

Four Republican senators sent a letter to Senate Majority Leader Mitch McConnell March 6 saying they do not support a recent Affordable Care Act "repeal and replacement" plan that is being circulated in the US Congress due to concerns about funding and coverage for Medicaid expansion. A copy of the letter to McConnell is available on Sen. Cory Gardner's, R-Colo., website.

Gardner, Rob Portman, R-Ohio, Shelley Moore Capito, R-W.Va., and Lisa Murkowski, R-Alaska, told McConnell in the letter that a Feb....

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Legislation

MI-PolicyAndRegulation (Free-1): Biliary Atresia Linked to Autism and Neurodevelopment Delays

 
• By Nabil

Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.

Better Coverage For Cancer Screening Tests On Horizon

 
• By Elizabeth Orr

Multi-cancer diagnostics can help get oncology patients the treatment they need more quickly, but lack of reimbursement has kept such tests out of reach for many patients. Bills providing coverage have passed or are under consideration in more than half of the states and have been introduced in both houses of US Congress.

FDA To Expand Postmarket Surveillance Of Medical Devices, Per GAO Report Requested By Lawmakers

 
• By Brian Bossetta

A government report requested by US lawmakers Debbie Dingell and Anna Eshoo to review the FDA’s postmarket surveillance of medical devices stresses that strengthening the system is critical to addressing adverse events linked to devices after they hit the market.

Legislation Could Bring Good News To Medicare Recipients With Severe Hearing Loss

 
• By Brian Bossetta

A bipartisan bill now in the US Senate seeks to change the classification of implantable hearing aid devices to allow Medicare to reimburse for the devices, potentially expanding access for many Americans who require them.

More from Policy & Regulation

News We’re Watching: New FDA Approvals For Breast Implant, Colon Cancer Test, Imaging Agent; TAP Expansion, AI Standards

This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.  

MI-PolicyAndRegulation (Free-1): Biliary Atresia Linked to Autism and Neurodevelopment Delays

 
• By Nabil

Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.

Sponsored By

Nancy Tests SPARC-931 Part 7

This is a description